Strategic Diagnostics Inc. (NASDAQ:SDIX), announced the publication of a comparative, in-depth study characterizing the strengths of its innovative DNA-immunization based Genomic Antibody Technology?, or GAT?. The article provides data that shows the significant advantage of SDIX's antibody technology versus current conventional approaches.

SDIX? (NASDAQ: SDIX), recently announced that it has successfully completed its previously announced sale of the assets of its water quality division to Modern Water plc for $4.5 million. Modern Water acquired the division's intellectual property, current inventory and commercial contracts, as well as its equipment and staff.